Purpose To analyze the 10-year biochemical relapse-free survival (BRFS), locoregional
relapse-free survival (LRFS), metastasis-free survival (MFS), and overall survival (OS) in …

Background Magnetic resonance imaging (MRI) of the prostate is considered to be the most
precise noninvasive staging modality for localized prostate cancer. Multiparametric MRI …

Purpose To investigate the impact of multiparametric magnetic resonance imaging (mpMRI)
on risk group assessment of patients with prostate cancer (PCa) initially addressed to …

Purpose To investigate patterns of practice among Spanish radiation oncologists in the use
of multiparametric magnetic resonance imaging (mpMRI) for the treatment of prostate cancer …

Purpose To prospectively determine whether multiparametric magnetic resonance imaging
(mpMRI)–based staging is a more accurate independent predictor of outcome than …

Abstract Objectives Prostate cancer (CaP) staging traditionally includes computed
tomography (CT) and technetium-99m bone scintigraphy (BS) for assessment of lymph node …

Purpose There is growing evidence supporting incorporating multiparametric (mp) magnetic
resonance imaging (MRI) scans into risk stratification, active surveillance, and treatment …

To assess and validate the incorporation of the multiparametric magnetic resonance
imaging (mpMRI) tumour category (mT-category) to the conventional clinical tumour …

OBJECTIVE. Despite a substantial increase in the use of MRI for pretreatment evaluation of
prostate cancer, its prognostic value in patients undergoing radiation therapy (RT) is not well …

Background Novel methods of risk stratification are needed for men with prostate cancer.
The Prostate Imaging Reporting and Data System (PI-RADS) uses multiparametric MRI …